Therapy for Venous Thrombosis: Guidelines for a Competent and Cost-effective Approach

Bick RL , Fareed J. Current status of thrombosis: a multidisciplinary medical issue and major American health problem— beyond the year 2000. Clin Appl Thromb Hemost 1997;3(suppl 1):1.

Heart and Stroke-1997 American Heart Association National Headquarters, Dallas Texas, 1996 .

Landis SH , Murray T. , Bolden S. Cancer Statistics Ca—Cancer J Clin 1998 ;48:6.

Bick RL , Kaplan H. Syndromes of thrombosis and hypercoagulability: congenital and acquired causes of thrombosis. Med Clin North Am 1998;82:409.

Bick RL , Jakway J. , Baker WF Deep vein thrombosis: prevalence of etiologic factors and results of management in 100 consecutive patients. Semin Thromb Hemost 1992:18:267.

Bergqvist D. , Lundblad B. Incidence of venous thromboembolism in medical and surgical patients. In: Bergqvist D , Comerota A , Nicolaides A , Scurr J , eds. Prevention of Venous Thromboembolism . London: Med-Orion Press, 1994:3.

Silverstein MD , Heit JA , Mohr DN , et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998;158:585.

Ramaswami G. , Nicolaides AN The natural history of deep vein thrombosis. In: Bergqvist D , Comerota A , Nicolaides A , Scurr J , eds. Prevention of Venous Thromboembolism. London : Med-Orion Press, 1994:3.

Bick RL , Ancypa D. , Blood protein defects associated with thrombosis: laboratory assessment. Clin Lab Med 1995;15:125.

MedPar : the MedStat Group Outcomes analysis. MedPar, 1998.

De Stefano V. , Finazzi G. , Mannucci PM Inherited thrombophilia: pathogenesis, clinical syndromes and management. Blood 1996; 87:353.

Bick RL Sticky Platelet Syndrome: a common cause of unexplained venous and arterial thrombosis-results of prevalence and treatment outcome. Clin Appl Thromb Hemost 1998;4:1.

Mammen EF Ten year's experience with the "Sticky Platelet Syndrome." Clin Appl Thromb Hemost 1995;1:66.

Bick RL The antiphospholipid thrombosis syndromes: a common multidisciplinary medical problem. Clin Appl Thromb Hemost 1997;3:270.

Bick RL Antiphospholipid thrombosis syndromes: etiology, pathophysiology, diagnosis and management. Int J Hematol 1997; 65:193.

Bick RL Syndromes of thrombosis and hypercoagulability: congenital and acquired thrombophilias . Clin Appl Thromb Hemost 1998;4:25.

Beyth RJ , Cohen AM , Landefeld CS Long-term outcomes of deep-vein thrombosis. Arch Intern Med 1995;155:1031.

Prandoni P. , Lensing Awa , Cogo A. , et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996 ; 125:1.

PHD Pharmacy Lett 1998;16:5.

Ardeparin and danaparoid for prevention of deep vein thrombosis . Med Lett 1997;39:94.

Haas SK Treatment of deep venous thrombosis: current recommendations. Med Clin North Am 1998;82:495.

Philbrick JT , Becker DM Calf deep vein thrombosis: a wolf in sheep's clothing? Arch Intern Med 1988;148:2131.

Baker WF , Bick RL Deep vein thrombosis: diagnosis and management. Med Clin North Am 1994:78:685.

Murano G. , Bell WR Thrombolytic therapy. In: Bick RL , Bennett JM , Brynes RK , eds. Hematology: Clinical and Laboratory Practice. Saint Louis: Mosby, 1993:1633.

Bell WR Thrombolytic therapy: agents, indications and laboratory monitoring. Med Clin North Am 1994;78:745.

Hoomes DW , Bura A. , Mazzolai L. , et al. Subcutaneous heparin compared with continuous intravenous heparin, administration in the initial treatment of deep vein thrombosis: a meta-analysis . Ann Intern Med 1992;116:279.

Bick RL , Haas SK International consensus recommendations: summary statement and additional suggested guidelines. Med Clin North Am 1998 ;82:613.

Hull RD , Raskob GE , Brant RF , et al. The importance of initial treatment on long-term outcomes of antithrombotic therapy. Arch Intern Med 1997 ;157:2317.

Walenga JM , Bick RL Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy. Med Clin North Am 1998;82:635.

The Columbus Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997;337:657.

Duroux P. A collaborative european multicentre study: a randomized trial of subcutaneous low molecular weight heparin (CY216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis. Thromb Haemost 1991;65:251.

Faivre R. , Neuhart Y. , Kieffer Y. , et al. Un nouveau traitement des thromboses veineuses profondes: les fractions d'heparine de bas poids moleculaire. Etude randomisee. Presse Méd 1988;17:197.

Fiessinger JN , Lopez-Fernandez M. , Gatterer E. , et al. Once-daily subcutaneous Dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis. Thromb Haemost 1996;76:195.

Hull RD , Raskob GE , Pineo GF , et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 1992;326:975.

Koopman Mmw , Prandoni P. , Piovella F. , et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996;334:682.

Levine M. , Gent M. , Hirsh J. , et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334:677.

Lindmarker P. , Holmstrom M. , Granqvist S. , et al. Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep venous thrombosis. Thromb Haemost 1994;72:186.

Lopaciuk S. , Meissner AJ , Filipecki S. , et al. Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial. Thromb Haemost 1992;68:14.

Luomanmaki K. and the Finnish multicentre group , et al. Low molecular weight heparin (Fragmin) once daily vs continuous infusion of standard heparin in the treatment of DVT [Abstract] . Haemostasis 1994;24(suppl 1):248.

Prandoni P. , Lensing Awa , Buller HR , et al. Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis . Lancet 1992;339: 441.

Simonneau G. , Charbonnier B. , Decousus H. , et al. Subcutaneous low molecular weight heparin compared with continuous intravenous unfractionated heparin in the initial treatment proximal vein thrombosis. Arch Intern Med 1993;153:1541.

Simonneau G. , Sors H. , Charbonnier B. , et al. for the THESEE Study Group. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 1997;337:663.

van den Belt Agm , Prins MH , Lensing Awa , et al. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. The Cochrane Library, Issue 2. Cochrane Review. Oxford: Update Software. 1998.

Hull RD , Raskob GE , Pineo GF , Brant RF The treatment of proximal vein thrombosis with subcutaneous low molecular weight heparin compared with continuous intravenous heparin. The Canadian-American Thrombosis Study Group. Clin Appl Thromb Hemost 1995;1:151.

Shafer AI Low-molecular-weight heparin—an opportunity for home treatment of venous thrombosis [Editorial]. N Engl J Med 1996;334:724.

Koopman Mmw , Prandoni P. , Piovella F. , et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996;334:682.

Levine M. , Gent M. , Hirsh J. , et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334:677.

Lindmarker P. , Holmstrom KM , Granquist S. , et al. Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis. Thromb Haemost 1994 ;72:186.